TX
Texas House Bill HB595

Texas 2015 - 84th Regular

Texas House Bill HB595 Compare Versions

OldNewDifferences
11 84R8342 GCB-F
22 By: Clardy, Price, Turner of Tarrant, H.B. No. 595
33 Villalba, Metcalf, et al.
44 Substitute the following for H.B. No. 595:
55 By: Herrero C.S.H.B. No. 595
66
77
88 A BILL TO BE ENTITLED
99 AN ACT
1010 relating to the addition of certain substances to Penalty Groups
1111 1-A and 2 of the Texas Controlled Substances Act for criminal
1212 prosecution and other purposes.
1313 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1414 SECTION 1. Section 481.002(50), Health and Safety Code, is
1515 amended to read as follows:
1616 (50) "Abuse unit" means:
1717 (A) except as provided by Paragraph (B):
1818 (i) a single unit on or in any adulterant,
1919 dilutant, or similar carrier medium, including marked or perforated
2020 blotter paper, a tablet, gelatin wafer, sugar cube, or stamp, or
2121 other medium that contains any amount of a controlled substance
2222 listed in Penalty Group 1-A, if the unit is commonly used in abuse
2323 of that substance; or
2424 (ii) each quarter-inch square section of
2525 paper, if the adulterant, dilutant, or carrier medium is paper not
2626 marked or perforated into individual abuse units; or
2727 (B) if the controlled substance is in liquid or
2828 solid form, 40 micrograms of the controlled substance including any
2929 adulterant or dilutant.
3030 SECTION 2. Section 481.1021, Health and Safety Code, is
3131 amended to read as follows:
3232 Sec. 481.1021. PENALTY GROUP 1-A. (a) Penalty Group 1-A
3333 consists of:
3434 (1) lysergic acid diethylamide (LSD), including its
3535 salts, isomers, and salts of isomers; and
3636 (2) compounds structurally derived from
3737 2,5-dimethoxyphenethylamine by substitution at the 1-amino
3838 nitrogen atom with a benzyl substituent, including:
3939 (A) compounds further modified by:
4040 (i) substitution in the phenethylamine ring
4141 at the 4- position to any extent (including alkyl, alkoxy,
4242 alkylenedioxy, haloalkyl, or halide substituents); or
4343 (ii) substitution in the benzyl ring to any
4444 extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
4545 halide substituents); and
4646 (B) by example, compounds such as:
4747 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)
4848 phenethylamine (trade or other names: 25B-NBOMe, 2C-B-NBOMe);
4949 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)
5050 phenethylamine (trade or other names: 25C-NBOMe, 2C-C-NBOMe);
5151 2,5-Dimethoxy-4-methyl-N-(2-methoxybenzyl)
5252 phenethylamine (trade or other names: 25D-NBOMe, 2C-D-NBOMe);
5353 4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)
5454 phenethylamine (trade or other names: 25E-NBOMe, 2C-E-NBOMe);
5555 2,5-Dimethoxy-N-(2-
5656 methoxybenzyl)phenethylamine (some trade and other names:
5757 25H-NBOMe, 2C-H-NBOMe);
5858 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)
5959 phenethylamine (some trade and other names: 25I-NBOMe,
6060 2C-I-NBOMe);
6161 4-Iodo-2,5-dimethoxy-N-
6262 benzylphenethylamine (trade or other name: 25I-NB);
6363 4-Iodo-2,5-dimethoxy-N-(2,3-
6464 methylenedioxybenzyl)phenethylamine (trade or other name:
6565 25I-NBMD);
6666 4-Iodo-2,5-dimethoxy-N-(2-
6767 fluorobenzyl)phenethylamine (trade or other name: 25I-NBF);
6868 4-Iodo-2,5-dimethoxy-N-(2-hydroxybenzyl)
6969 phenethylamine (trade or other name: 25I-NBOH);
7070 2,5-Dimethoxy-4-nitro-N-(2-methoxybenzyl)
7171 phenethylamine (trade or other names: 25N-NBOMe, 2C-N-NBOMe); and
7272 2,5-Dimethoxy-4-(n)-propyl-N-(2-
7373 methoxybenzyl)phenethylamine (some trade and other names:
7474 25P-NBOMe, 2C-P-NBOMe).
7575 (b) To the extent Subsection (a)(2) conflicts with another
7676 provision of this subtitle or another law, the other provision or
7777 the other law prevails.
7878 SECTION 3. Section 481.103, Health and Safety Code, is
7979 amended by amending Subsections (a) and (c) and adding Subsection
8080 (d) to read as follows:
8181 (a) Penalty Group 2 consists of:
8282 (1) any quantity of the following hallucinogenic
8383 substances, their salts, isomers, and salts of isomers, unless
8484 specifically excepted, if the existence of these salts, isomers,
8585 and salts of isomers is possible within the specific chemical
8686 designation:
8787 5-(2-aminopropyl)benzofuran (5-APB);
8888 6-(2-aminopropyl)benzofuran (6-APB);
8989 5-(2-aminopropyl)-2,3-dihydrobenzofuran
9090 (5-APDB);
9191 6-(2-aminopropyl)-2,3-dihydrobenzofuran
9292 (6-APDB);
9393 5-(2-aminopropyl)indole (5-IT,5-API);
9494 6-(2-aminopropyl)indole (6-IT,6-API);
9595 1-(benzofuran-5-yl)-N-methylpropan-2-amine
9696 (5-MAPB);
9797 1-(benzofuran-6-yl)-N-methylpropan-2-amine
9898 (6-MAPB);
9999 Benzothiophenylcyclohexylpiperidine (BTCP);
100100 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
101101 4-ethanamine (trade or other name: Bromo-DragonFLY);
102102 Desoxypipradrol (2-benzhydrylpiperidine);
103103 [alpha-ethyltryptamine;
104104 [alpha-methyltryptamine;
105105 [4-bromo-2, 5-dimethoxyamphetamine (some trade or
106106 other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
107107 4-bromo-2, 5-DMA);
108108 [4-bromo-2, 5-dimethoxyphenethylamine;
109109 [Bufotenine (some trade and other
110110 names: 3-(beta- Dimethylaminoethyl)-5-hydroxyindole;
111111 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
112112 5-hydroxy-N, N- dimethyltryptamine; mappine);
113113 [Diethyltryptamine (some trade and other
114114 names: N, N-Diethyltryptamine, DET);]
115115 2, 5-dimethoxyamphetamine (some trade or other
116116 names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
117117 Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
118118 methanol, D2PM);
119119 [2, 5-dimethoxy-4-ethylamphetamine (trade or
120120 other name: DOET);
121121 [2, 5-dimethoxy-4-(n)-propylthiophenethylamine
122122 (trade or other name: 2C-T-7);
123123 [Dimethyltryptamine (trade or other name: DMT);]
124124 Dronabinol (synthetic) in sesame oil and
125125 encapsulated in a soft gelatin capsule in a U.S. Food and Drug
126126 Administration approved drug product (some trade or other names for
127127 Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
128128 trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
129129 (trans)- tetrahydrocannabinol);
130130 Ethylamine Analog of Phencyclidine (some trade or
131131 other names: N-ethyl-1-phenylcyclohexylamine, (1-
132132 phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
133133 cyclohexamine, PCE);
134134 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
135135 (trade or other name: methoxetamine);
136136 Ibogaine (some trade or other names: 7-Ethyl-6,
137137 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
138138 pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
139139 5-iodo-2-aminoindane (5-IAI);
140140 Mescaline;
141141 [5-methoxy-N, N-diisopropyltryptamine;]
142142 5-methoxy-3, 4-methylenedioxy amphetamine;
143143 4-methoxyamphetamine (some trade or other
144144 names: 4-methoxy-alpha-methylphenethylamine;
145145 paramethoxyamphetamine; PMA);
146146 4-methoxymethamphetamine (PMMA);
147147 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
148148 (some trade and other names: 2-MeO-ketamine; methoxyketamine);
149149 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
150150 PPMP);
151151 4-methyl-2, 5-dimethoxyamphetamine (some trade
152152 and other names: 4-methyl-2, 5-dimethoxy-alpha-
153153 methylphenethylamine; "DOM"; "STP");
154154 3,4-methylenedioxy methamphetamine (MDMA, MDM);
155155 3,4-methylenedioxy amphetamine;
156156 3,4-methylenedioxy N-ethylamphetamine (Also
157157 known as N-ethyl MDA);
158158 5,6-methylenedioxy-2-aminoindane (MDAI);
159159 Nabilone (Another name for nabilone: (+)-trans-
160160 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
161161 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
162162 N-benzylpiperazine (some trade or other
163163 names: BZP; 1-benzylpiperazine);
164164 N-ethyl-3-piperidyl benzilate;
165165 N-hydroxy-3,4-methylenedioxyamphetamine (Also
166166 known as N-hydroxy MDA);
167167 4-methylaminorex;
168168 N-methyl-3-piperidyl benzilate;
169169 Parahexyl (some trade or other names: 3-Hexyl-1-
170170 hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
171171 pyran; Synhexyl);
172172 1-Phenylcyclohexylamine;
173173 1-Piperidinocyclohexanecarbonitrile (PCC);
174174 [Psilocin;
175175 [Psilocybin;]
176176 Pyrrolidine Analog of Phencyclidine (some trade
177177 or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
178178 Tetrahydrocannabinols, other than marihuana, and
179179 synthetic equivalents of the substances contained in the plant, or
180180 in the resinous extractives of Cannabis, or synthetic substances,
181181 derivatives, and their isomers with similar chemical structure and
182182 pharmacological activity such as:
183183 delta-1 cis or trans tetrahydrocannabinol,
184184 and their optical isomers;
185185 delta-6 cis or trans tetrahydrocannabinol,
186186 and their optical isomers;
187187 delta-3, 4 cis or trans
188188 tetrahydrocannabinol, and its optical isomers; or
189189 compounds of these structures, regardless of
190190 numerical designation of atomic positions, since nomenclature of
191191 these substances is not internationally standardized;
192192 Thiophene Analog of Phencyclidine (some trade or
193193 other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
194194 Analog of Phencyclidine; TPCP, TCP);
195195 1-pyrrolidine (some trade or other name: TCPy);
196196 1-(3-trifluoromethylphenyl)piperazine (trade or
197197 other name: TFMPP); and
198198 3,4,5-trimethoxy amphetamine;
199199 (2) Phenylacetone (some trade or other
200200 names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
201201 ketone);
202202 (3) unless specifically excepted or unless listed in
203203 another Penalty Group, a material, compound, mixture, or
204204 preparation that contains any quantity of the following substances
205205 having a potential for abuse associated with a depressant or
206206 stimulant effect on the central nervous system:
207207 Aminorex (some trade or other
208208 names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
209209 phenyl-2-oxazolamine);
210210 Amphetamine, its salts, optical isomers, and
211211 salts of optical isomers;
212212 Cathinone (some trade or other names: 2-amino-1-
213213 phenyl-1-propanone, alpha-aminopropiophenone, 2-
214214 aminopropiophenone);
215215 Etaqualone and its salts;
216216 Etorphine Hydrochloride;
217217 Fenethylline and its salts;
218218 Lisdexamfetamine, including its salts, isomers,
219219 and salts of isomers;
220220 Mecloqualone and its salts;
221221 Methaqualone and its salts;
222222 Methcathinone (some trade or other names: 2-
223223 methylamino-propiophenone; alpha-(methylamino)propriophenone;
224224 2-(methylamino)-1-phenylpropan-1-one; alpha-N-
225225 methylaminopropriophenone; monomethylpropion; ephedrone, N-
226226 methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
227227 1431);
228228 N-Ethylamphetamine, its salts, optical isomers,
229229 and salts of optical isomers; and
230230 N,N-dimethylamphetamine (some trade or other
231231 names: N,N,alpha-trimethylbenzeneethanamine
232232 [N,N,alpha-trimethylbenzeneethaneamine];
233233 N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
234234 and salts of optical isomers; [and]
235235 (4) any compound structurally derived from
236236 2-aminopropanal by substitution at the 1-position with any
237237 monocyclic or fused-polycyclic ring system, including:
238238 (A) compounds further modified by:
239239 (i) substitution in the ring system to any
240240 extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
241241 halide substituents), whether or not further substituted in the
242242 ring system by other substituents;
243243 (ii) substitution at the 3-position with an
244244 alkyl substituent; or
245245 (iii) substitution at the 2-amino nitrogen
246246 atom with alkyl, benzyl, [or] dialkyl, or methoxybenzyl groups, or
247247 inclusion of the 2-amino nitrogen atom in a cyclic structure; and
248248 (B) by example, compounds such as:
249249 4-Methylmethcathinone (Also known as
250250 Mephedrone);
251251 3,4-Dimethylmethcathinone (Also known as
252252 3,4-DMMC);
253253 3-Fluoromethcathinone (Also known as 3-FMC);
254254 4-Fluoromethcathinone (Also known as
255255 Flephedrone);
256256 3,4-Methylenedioxy-N-methylcathinone (Also
257257 known as Methylone);
258258 3,4-Methylenedioxypyrovalerone (Also known
259259 as MDPV);
260260 alpha-Pyrrolidinopentiophenone (Also known
261261 as alpha-PVP);
262262 Naphthylpyrovalerone (Also known as
263263 Naphyrone);
264264 alpha-Methylamino-valerophenone (Also known
265265 as Pentedrone);
266266 beta-Keto-N-methylbenzodioxolylpropylamine
267267 (Also known as Butylone);
268268 beta-Keto-N-methylbenzodioxolylpentanamine
269269 (Also known as Pentylone);
270270 beta-Keto-Ethylbenzodioxolylbutanamine
271271 (Also known as Eutylone); and
272272 3,4-methylenedioxy-N-ethylcathinone (Also
273273 known as Ethylone);
274274 (5) any compound structurally derived from tryptamine
275275 (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
276276 (A) by modification in any of the following ways:
277277 (i) by substitution at the amine nitrogen
278278 atom of the sidechain to any extent with alkyl or alkenyl groups or
279279 by inclusion of the amine nitrogen atom of the side chain (and no
280280 other atoms of the side chain) in a cyclic structure;
281281 (ii) by substitution at the carbon atom
282282 adjacent to the nitrogen atom of the side chain (alpha-position)
283283 with an alkyl or alkenyl group;
284284 (iii) by substitution in the 6-membered
285285 ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
286286 alkylenedioxy, or halide substituents; or
287287 (iv) by substitution at the 2-position of
288288 the tryptamine ring system with an alkyl substituent; and
289289 (B) including:
290290 (i) ethers and esters of the controlled
291291 substances listed in this subdivision; and
292292 (ii) by example, compounds such as:
293293 alpha-ethyltryptamine;
294294 alpha-methyltryptamine;
295295 Bufotenine (some trade and other names:
296296 3-(beta- Dimethylaminoethyl)-5-hydroxyindole;
297297 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
298298 5-hydroxy-N, N- dimethyltryptamine; mappine);
299299 Diethyltryptamine (some trade and
300300 other names: N, N-Diethyltryptamine, DET);
301301 Dimethyltryptamine (trade or other
302302 name: DMT);
303303 5-methoxy-N, N-diisopropyltryptamine
304304 (5-MeO-DiPT);
305305 O-Acetylpsilocin (Trade or other name:
306306 4-Aco-DMT);
307307 Psilocin; and
308308 Psilocybin;
309309 (6) 2,5-Dimethoxyphenethylamine and any compound
310310 structurally derived from 2,5-Dimethoxyphenethylamine by
311311 substitution at the 4-position of the phenyl ring to any extent
312312 (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
313313 substituents), including, by example, compounds such as:
314314 4-Bromo-2,5-dimethoxyphenethylamine (trade or
315315 other name: 2C-B);
316316 4-Chloro-2,5-dimethoxyphenethylamine (trade or
317317 other name: 2C-C);
318318 2,5-Dimethoxy-4-methylphenethylamine (trade or
319319 other name: 2C-D);
320320 4-Ethyl-2,5-dimethoxyphenethylamine (trade or
321321 other name: 2C-E);
322322 4-Iodo-2,5-dimethoxyphenethylamine (trade or
323323 other name: 2C-I);
324324 2,5-Dimethoxy-4-nitrophenethylamine (trade or
325325 other name: 2C-N);
326326 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
327327 or other name: 2C-P);
328328 4-Ethylthio-2,5-dimethoxyphenethylamine (trade
329329 or other name: 2C-T-2);
330330 4-Isopropylthio-2,5-dimethoxyphenethylamine
331331 (trade or other name: 2C-T-4); and
332332 2,5-Dimethoxy-4-(n)-propylthiophenethylamine
333333 (trade or other name: 2C-T-7); and
334334 (7) 2,5-Dimethoxyamphetamine and any compound
335335 structurally derived from 2,5-Dimethoxyamphetamine by substitution
336336 at the 4-position of the phenyl ring to any extent (including alkyl,
337337 alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
338338 including, by example, compounds such as:
339339 4-Ethylthio-2,5-dimethoxyamphetamine (trade or
340340 other name: Aleph-2);
341341 4-Isopropylthio-2,5-dimethoxyamphetamine (trade
342342 or other name: Aleph-4);
343343 4-Bromo-2,5-dimethoxyamphetamine (trade or other
344344 name: DOB);
345345 4-Chloro-2,5-dimethoxyamphetamine (trade or
346346 other name: DOC);
347347 2,5-Dimethoxy-4-ethylamphetamine (trade or other
348348 name: DOET);
349349 4-Iodo-2,5-dimethoxyamphetamine (trade or other
350350 name: DOI);
351351 2,5-Dimethoxy-4-methylamphetamine (trade or
352352 other name: DOM);
353353 2,5-Dimethoxy-4-nitroamphetamine (trade or other
354354 name: DON);
355355 4-Isopropyl-2,5-dimethoxyamphetamine (trade or
356356 other name: DOIP); and
357357 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
358358 other name: DOPR).
359359 (c) To the extent Subsection (a)(4), (5), (6), or (7)
360360 conflicts with another provision or this subtitle or another law,
361361 the other provision [subtitle] or the other law prevails. If a
362362 substance listed in this section is also listed in another penalty
363363 group, the listing in the other penalty group controls.
364364 (d) If a substance listed in this section is approved by the
365365 Federal Drug Administration, the inclusion of that substance in
366366 this penalty group does not apply, and notwithstanding any other
367367 law, a person may not be convicted for the manufacture or delivery
368368 of the substance under Section 481.113 or for possession of the
369369 substance under Section 481.116.
370370 SECTION 4. The change in law made by this Act applies only
371371 to an offense committed on or after the effective date of this Act.
372372 An offense committed before the effective date of this Act is
373373 governed by the law in effect on the date the offense was committed,
374374 and the former law is continued in effect for that purpose. For
375375 purposes of this section, an offense was committed before the
376376 effective date of this Act if any element of the offense occurred
377377 before that date.
378378 SECTION 5. This Act takes effect September 1, 2015.